<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cfpd</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень физиологии и патологии дыхания</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin Physiology and Pathology of Respiration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1998-5029</issn><publisher><publisher-name>Дальневосточный научный центр физиологии и патологии дыхания</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">cfpd-505</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>ПРОГНОЗИРОВАНИЕ ЧАСТОТЫ ОБОСТРЕНИЯ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ, СОЧЕТАННОЙ С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА</article-title><trans-title-group xml:lang="en"><trans-title>PROGNOSTICATION OF THE FREQUENCY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION COMBINED WITH THE ISHEMIC HEART DISEASE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колосов</surname><given-names>Виктор Павлович</given-names></name><name name-style="western" xml:lang="en"><surname>Kolosov</surname><given-names>Viktor P.</given-names></name></name-alternatives><email xlink:type="simple">dncfpd@ramn.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павленко</surname><given-names>Валентина Ивановна</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlenko</surname><given-names>Valentina I.</given-names></name></name-alternatives><email xlink:type="simple">amurvip@front.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Дальневосточный научный центр физиологии и патологии дыхания Сибирского отделения РАМН</institution></aff><aff xml:lang="en"><institution>Far Eastern Scientific Center of Physiology and Pathology of Respiration SB RAMS</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Амурская государственная медицинская академия</institution></aff><aff xml:lang="en"><institution>Amur State Medical Academy</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>19</day><month>02</month><year>2020</year></pub-date><volume>0</volume><issue>45</issue><fpage>35</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Колосов В.П., Павленко В.И., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Колосов В.П., Павленко В.И.</copyright-holder><copyright-holder xml:lang="en">Kolosov V.P., Pavlenko V.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cfpd.elpub.ru/jour/article/view/505">https://cfpd.elpub.ru/jour/article/view/505</self-uri><abstract><p>Изучены возможности прогнозирования частого обострения хронической обструктивной болезни легких (ХОБЛ), сочетанной с ишемической болезнью сердца (ИБС) путем оценки уровня показателей системного воспаления в плазме крови (С-реактивного белка, TNF-α, IL-6, IL-8, лейкоцитов, фибриногена) и противовоспалительного цитокина IL-4. Проведено комплексное клинико-лабораторное обследование 88 больных ХОБЛ, сочетанной с ИБС. Из них у 36 пациентов в течение 12 месяцев установлена частота обострения ХОБЛ до 2 раз (1 группа), и у 52 больных - более 2 раз (2 группа). Установлено, что у пациентов во 2 группе концентрация биомаркеров системного воспаления значительно превышала показатели у больных в 1 группе. Статистически значимые различия определены в содержании С-реактивного белка (3,78±0,14 и 3,21±0,11 г/л, соответственно, р&lt;0,05), TNF-α (7,64±0,32 и 4,92±0,22 пг/л, соответственно, р&lt;0,001), IL-8 (19,73±1,19 и 15,90±1,21 пг/л, соответственно, р&lt;0,05). При этом уровень IL-4 во 2 группе был ниже, чем в 1 группе (6,12±0,10 и 8,23±0,65 пг/л, соответственно, р&lt;0,01). На основании установленных закономерностей предложен способ прогнозирования частого обострения ХОБЛ, сочетанной с ИБС, с помощью интегральной оценки указанных показателей путем решения дискриминантного уравнения. Данная математическая модель прогнозирования является простым и доступным методом, позволяющим принять решение для проведения индивидуальных лечебно-профилактических мероприятий у пациентов данной категории.</p></abstract><trans-abstract xml:lang="en"><p>The possibilities of prognostication of frequent exacerbation of chronic obstructive pulmonary disease (COPD) combined with the ischemic heart disease (IHD) by the estimation of parameters of system inflammation in blood plasma (С-reactive protein, TNF-α, IL-6, IL-8, leukocytes, fibrinogen) and anti-inflammatory IL-4 were studied. Complex clinical and laboratory examination of 88 COPD patients with IHD was done. 36 patients during 12 months were found to have an acute form of COPD for no more than 2 times (the first group), and 52 patients had it for more than two times (the second group). It was found out that in the patients of the second group the concentration of biomarkers of system inflammation was significantly higher than in the patients of the first group. Statistically important differences were revealed in the content of C-reactive protein (3.78±0.14 and 3.21±0.11 g/l, respectively, р&lt;0.05), TNF-α (7.64±0.32 and 4.92±0.22 pg/l, respectively, р&lt;0,001), IL-8 (19.73±1.19 and 15.90±1.21 pg/l, respectively, р&lt;0.05). At the same time the level of IL-4 in the second group was lower than in the first group (6.12±0.10 and 8.23±0.65 pg/l, respectively, р&lt;0.01). On the basis of the revealed regularities the method of prognostication of frequent COPD exacerbation combined with IHD was offered with the help of integral estimation of the mentioned parameters by doing the discriminant equation. This mathematical model of prognostication is a simple and accessible method which allows to make a decision about individual treatment and prophylaxis in such-like patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая обструктивная болезнь легких</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>системное воспаление</kwd><kwd>прогнозирование частоты обострения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic obstructive pulmonary disease</kwd><kwd>ischemic heart disease</kwd><kwd>systemic inflammation</kwd><kwd>prognostication of frequency exacerbation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Аверьянов А.В., Зыков К.А. Хроническая обструктивная болезнь легких с частыми обострениями: возможные пути решения проблемы // Справочник поликлин. врача. 2009. №2. С.38-42.</mixed-citation><mixed-citation xml:lang="en">Аверьянов А.В., Зыков К.А. Хроническая обструктивная болезнь легких с частыми обострениями: возможные пути решения проблемы // Справочник поликлин. врача. 2009. №2. С.38-42.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Авдеев С.Н. Антибактериальная терапия при обострении хронической обструктивной болезни легких // Consilium medicum. 2010. №3. С.12-18.</mixed-citation><mixed-citation xml:lang="en">Авдеев С.Н. Антибактериальная терапия при обострении хронической обструктивной болезни легких // Consilium medicum. 2010. №3. С.12-18.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Овчаренко С.И. Хроническая обструктивная болезнь легких: реальная ситуация в России и пути ее преодоления // Пульмонология. 2011. №6.С.69-72.</mixed-citation><mixed-citation xml:lang="en">Овчаренко С.И. Хроническая обструктивная болезнь легких: реальная ситуация в России и пути ее преодоления // Пульмонология. 2011. №6.С.69-72.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease / G.C.Donaldson [et al.] // Thorax. 2002. Vol.57, №10. P.847-852.</mixed-citation><mixed-citation xml:lang="en">Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease / G.C.Donaldson [et al.] // Thorax. 2002. Vol.57, №10. P.847-852.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Huertas A., Palange P. COPD: а multifactorial systemic diasese // Ther. Adv. Respir. Dis. 2011. Vol.5, №3. P.217-224.</mixed-citation><mixed-citation xml:lang="en">Huertas A., Palange P. COPD: а multifactorial systemic diasese // Ther. Adv. Respir. Dis. 2011. Vol.5, №3. P.217-224.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations // Chest. 2000. Vol.117, №5(Suppl.2). P.398S-401S.</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations // Chest. 2000. Vol.117, №5(Suppl.2). P.398S-401S.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Roisin R. COPD exacerbations∙5: Management // Thorax. 2006.Vol.61, №6. P.535-544.</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Roisin R. COPD exacerbations∙5: Management // Thorax. 2006.Vol.61, №6. P.535-544.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Stanford R.H., Shen Y., McLaughlin T. Cost of chronic obstructive pulmonary disease in the emergency department and hospital: an analysis of administrative data from 218 US hospitals // Treat. Respir. Med. 2006. Vol.5, №5. P.343-349.</mixed-citation><mixed-citation xml:lang="en">Stanford R.H., Shen Y., McLaughlin T. Cost of chronic obstructive pulmonary disease in the emergency department and hospital: an analysis of administrative data from 218 US hospitals // Treat. Respir. Med. 2006. Vol.5, №5. P.343-349.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Aver'yanov A.V., Zykov K.A. Spravochnik poliklinicheskogo vracha 2009; 2:38-42.</mixed-citation><mixed-citation xml:lang="en">Aver'yanov A.V., Zykov K.A. Spravochnik poliklinicheskogo vracha 2009; 2:38-42.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Avdeev S.N. Consilium medicum 2010;3:12-18.</mixed-citation><mixed-citation xml:lang="en">Avdeev S.N. Consilium medicum 2010;3:12-18.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ovcharenko S.I. Pul'monologiya 2011; 6:69-72.</mixed-citation><mixed-citation xml:lang="en">Ovcharenko S.I. Pul'monologiya 2011; 6:69-72.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Donaldson G.C., Seemungal T.A.R., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57(10):847-852.</mixed-citation><mixed-citation xml:lang="en">Donaldson G.C., Seemungal T.A.R., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57(10):847-852.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Huertas A., Palange P. COPD: а multifactorial systemic diasese. Ther. Adv. Respir. Dis. 2011; 5(3):217-224.</mixed-citation><mixed-citation xml:lang="en">Huertas A., Palange P. COPD: а multifactorial systemic diasese. Ther. Adv. Respir. Dis. 2011; 5(3):217-224.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117 (5 Suppl. 2):398S-401S.</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117 (5 Suppl. 2):398S-401S.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Roisin R. COPD exacerbations∙5: Management. Thorax 2006; 61(6):535-544.</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Roisin R. COPD exacerbations∙5: Management. Thorax 2006; 61(6):535-544.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Stanford R.H., Shen Y., McLaughlin T. Cost of chronic obstructive pulmonary disease in the emergency department and hospital: an analysis of administrative data from 218 US hospitals. Treat. Respir. Med. 2006; 5(5):343-349.</mixed-citation><mixed-citation xml:lang="en">Stanford R.H., Shen Y., McLaughlin T. Cost of chronic obstructive pulmonary disease in the emergency department and hospital: an analysis of administrative data from 218 US hospitals. Treat. Respir. Med. 2006; 5(5):343-349.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
